 | • レポートコード：MRC2303J0204 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、246ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界のスマートシリンジ市場規模が2021年に5,535.53百万ドル、2022年には6,827.52百万ドルに到達し、今後CAGR 24.03％で成長して2027年までに20,158.50百万ドルまで拡大すると予測しています。当調査資料では、スマートシリンジの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、治療方法別（アクティブセーフティシリンジ、自動無効化シリンジ、パッシブセーフティシリンジ）分析、用途別（血液検体採取、ドラッグデリバリー、ワクチン）分析、エンドユーザー別（診断センター、病院＆HMO、クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、AdvaCare Pharma、B. Braun Melsungen AG、Baxter International Inc.、Becton, Dickinson and Company、Biocorp、Cardinal Health, Inc.、DMC Medical Limited、Gerresheimer AG、Hindustan Syringes & Medical Devices Ltd.、Medtronic PLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のスマートシリンジ市場規模：治療方法別 - アクティブセーフティシリンジの市場規模 - 自動無効化シリンジの市場規模 - パッシブセーフティシリンジの市場規模 ・世界のスマートシリンジ市場規模：用途別 - 血液検体採取における市場規模 - ドラッグデリバリーにおける市場規模 - ワクチンにおける市場規模 ・世界のスマートシリンジ市場規模：エンドユーザー別 - 診断センターにおける市場規模 - 病院＆HMOにおける市場規模 - クリニックにおける市場規模 ・世界のスマートシリンジ市場規模：地域別 - 南北アメリカのスマートシリンジ市場規模 アメリカのスマートシリンジ市場規模 カナダのスマートシリンジ市場規模 ブラジルのスマートシリンジ市場規模 ... - アジア太平洋のスマートシリンジ市場規模 日本のスマートシリンジ市場規模 中国のスマートシリンジ市場規模 インドのスマートシリンジ市場規模 韓国のスマートシリンジ市場規模 台湾のスマートシリンジ市場規模 ... - ヨーロッパ/中東/アフリカのスマートシリンジ市場規模 イギリスのスマートシリンジ市場規模 ドイツのスマートシリンジ市場規模 フランスのスマートシリンジ市場規模 ロシアのスマートシリンジ市場規模 ... - その他地域のスマートシリンジ市場規模 ・競争状況 ・企業情報 |
The Global Smart Syringes Market size was estimated at USD 5,535.53 million in 2021 and expected to reach USD 6,827.52 million in 2022, and is projected to grow at a CAGR 24.03% to reach USD 20,158.50 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Smart Syringes to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Theraupetics, the market was studied across Active Safety Syringes, Auto-disable Syringes, and Passive Safety Syringes.
Based on Application, the market was studied across Blood Specimen Collection, Drug Delivery, and Vaccination.
Based on End User, the market was studied across Diagnostics Center, Hospitals & HMOs, and Physician Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smart Syringes market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Syringes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Smart Syringes Market, including AdvaCare Pharma, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Biocorp, Cardinal Health, Inc., DMC Medical Limited, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Medtronic PLC, MHC Medical Products, LLC, Numedico Technologies Pty Ltd., Owen Mumford Limited, Parker-Hannifin Corporation, Retractable Technologies, Inc., Sharps Technology, Inc., Smiths Group PLC, Sol-Millennium Medical Group, Terumo Corporation, and UltiMed, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Smart Syringes Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smart Syringes Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smart Syringes Market?
4. What is the competitive strategic window for opportunities in the Global Smart Syringes Market?
5. What are the technology trends and regulatory frameworks in the Global Smart Syringes Market?
6. What is the market share of the leading vendors in the Global Smart Syringes Market?
7. What modes and strategic moves are considered suitable for entering the Global Smart Syringes Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
5.1.1.2. Increasing Number of Vaccination Campaigns and Initiatives
5.1.1.3. Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
5.1.2. Restraints
5.1.2.1. Smart Syringes Product Recalls
5.1.3. Opportunities
5.1.3.1. Growing Need for Environmentally Safe and Auto Disable Syringes
5.1.3.2. Stringent Regulation for Patient Health and Safety
5.1.4. Challenges
5.1.4.1. Low Awareness and Usage of Smart Syringes in Developing Countries
5.2. Cumulative Impact of COVID-19
6. Smart Syringes Market, by Theraupetics
6.1. Introduction
6.2. Active Safety Syringes
6.3. Auto-disable Syringes
6.4. Passive Safety Syringes
7. Smart Syringes Market, by Application
7.1. Introduction
7.2. Blood Specimen Collection
7.3. Drug Delivery
7.4. Vaccination
8. Smart Syringes Market, by End User
8.1. Introduction
8.2. Diagnostics Center
8.3. Hospitals & HMOs
8.4. Physician Clinics
9. Americas Smart Syringes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Smart Syringes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Smart Syringes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AdvaCare Pharma
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. B. Braun Melsungen AG
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Baxter International Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Becton, Dickinson and Company
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Biocorp
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardinal Health, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. DMC Medical Limited
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Gerresheimer AG
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Hindustan Syringes & Medical Devices Ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Medtronic PLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. MHC Medical Products, LLC
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Numedico Technologies Pty Ltd.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Owen Mumford Limited
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Parker-Hannifin Corporation
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Retractable Technologies, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Sharps Technology, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Smiths Group PLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Sol-Millennium Medical Group
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Terumo Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. UltiMed, Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing